Inspirna, Inc. (formerly known as Rgenix, Inc.) is developing first-in-class drugs that target key pathways in cancer progression.
Colossal Biosciences
9 followers
Calico
8 followers
Vera Therapeutics
6 followers
Mineralys Therapeutics
3 followers
CG Oncology
2 followers
Kyverna Therapeutics
7 followers
Cogent Biosciences
1 follower
Celcuity
1 follower
Immunic Therapeutics
1 follower
Gloucester Marine Genomics Institute
1 follower
BioTuring
1 follower
BioAge
3 followers